Sintx Technologies, Inc. (SINT) Fair Value 2026

SINT · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.7 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (35/100)

Quick Summary — As of 2026-10-07, Sintx Technologies, Inc. (SINT) trades at $2.18. QOC: 5.7/10. Value Trap Risk: 35/100 (LOW). 1/13 models active.

Key Facts

Ticker
SINT
Price
$2.18
Quality Score
5.7/10
Value Trap Risk
35/100
Models Active
1/13
Last Updated
Strength: Dynamic NAV suggests +115.3% upside with 52% confidence
Risk: Limited model coverage (1/13) may reduce confidence

What Fair Value Does Each Model Give SINT?

1 Intrinsic Value Models vs. Current Price ($2.18)

Core Models (Unlocked)
Model Fair Value Upside
Asset-Based · High Conviction
 $4.69 +115.3%

All Models Active

All 1 models are displayed above.

What Is Sintx Technologies, Inc. (SINT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Sintx Technologies, Inc.. Trading at $2.18 against an estimated intrinsic value of $4.69, 1 of 1 active models flag meaningful upside of +115.3% at the median.

What Do the Models Say About SINT?

1 of 13 models are currently active for SINT. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does SINT Rank in Medical Devices?

Among 161 Medical Devices stocks, SINT ranks #105 by Quality of Company score. CirclFi's QOC score of 5.7/10 evaluates 32 fundamental signals. A score of 5.7 reflects mixed fundamentals.

See all Most Undervalued Medical Devices Stocks →

Sintx Technologies, Inc.'s positioning within the Medical Devices segment means that FDA approval probability plays an outsized role in fundamental analysis. The sector's unique characteristics — including late-stage pipeline catalysts — shape both the opportunity set and risk profile.

Is SINT a Value Trap?

CirclFi's Value Trap algorithm assigns SINT a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Sintx Technologies, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, Sintx Technologies, Inc. earns a quality score of 5.7/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every SINT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across SINT's 1 active models, average confidence is 52%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Sintx Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

TLSITriSalus Life Sciences, Inc.QOC 5.7PACBPacific Biosciences of California, Inc.QOC 5.6CVCapsoVision, Inc.QOC 5.7LFWDLifeward Ltd.QOC 5.6VNRXVolitionRx LimitedQOC 5.8QTIQT Imaging Holdings, Inc.QOC 5.6POSCPositron CorporationQOC 4.3MDNCMedinotec Inc.QOC 8.2NSYSNortech Systems IncorporatedQOC 6.6IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: TLSI · PACB · CV · LFWD · VNRX · QTI · POSC · MDNC · NSYS · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to SINT?

7 companies across all industries closest to SINT’s Quality of Company score of 5.7/10.

VISLVislink Technologies, Inc.QOC 5.7SVRESaverOne 2014 Ltd.QOC 5.7HUTHut 8 Corp.QOC 5.7OTLCOncotelic Therapeutics, Inc.QOC 5.7APCXAppTech Payments Corp.QOC 5.7VRNOVerano Holdings Corp.QOC 5.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: VISL · SVRE · HUT · OTLC · APCX · VRNO · NVDA

Where Does SINT Sit in CirclFi's Medical Devices Rankings?

SINT is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Sintx Technologies, Inc.’s Valuation?

What is Sintx Technologies, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Sintx Technologies, Inc. (SINT). The Quality of Company score is 5.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is SINT overvalued or undervalued right now?

At $2.18, 1 of 1 active models suggest SINT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Sintx Technologies, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 5.7 mean for SINT?

Sintx Technologies, Inc.'s QOC of 5.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on SINT?

CirclFi analyzes SINT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is SINT a value trap in 2026?

Sintx Technologies, Inc.'s Value Trap score is 35/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Sintx Technologies, Inc. (SINT) a Quality of Company score of 5.7/10 across 32 fundamental signals as of 2026-10-07.” Source: circlfi.com/stock/SINT/ · Methodology
Primary sources for this SINT valuation
  • Financial statements: Sintx Technologies, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001269026) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for SINT as of ; valuations recomputed .